Ming Y. Lim

1.4k total citations
86 papers, 663 citations indexed

About

Ming Y. Lim is a scholar working on Hematology, Internal Medicine and Genetics. According to data from OpenAlex, Ming Y. Lim has authored 86 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 22 papers in Internal Medicine and 16 papers in Genetics. Recurrent topics in Ming Y. Lim's work include Venous Thromboembolism Diagnosis and Management (22 papers), Hemophilia Treatment and Research (18 papers) and Platelet Disorders and Treatments (12 papers). Ming Y. Lim is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (22 papers), Hemophilia Treatment and Research (18 papers) and Platelet Disorders and Treatments (12 papers). Ming Y. Lim collaborates with scholars based in United States, Canada and United Kingdom. Ming Y. Lim's co-authors include Nigel S. Key, Rajiv K. Pruthi, Kenneth I. Ataga, Mouhamed Yazan Abou‐Ismail, Charles S. Greenberg, Jori E. May, Vinay Mathew Thomas, D. Ware Branch, Alisa S. Wolberg and Matthew F. Whelihan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ming Y. Lim

73 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Y. Lim United States 13 377 194 175 109 88 86 663
Melvin R. Mac Gillavry Netherlands 13 210 0.6× 208 1.1× 303 1.7× 278 2.6× 58 0.7× 21 745
Janet Birchall United Kingdom 11 484 1.3× 123 0.6× 77 0.4× 74 0.7× 143 1.6× 21 916
Terry Gernsheimer United States 14 280 0.7× 80 0.4× 89 0.5× 61 0.6× 126 1.4× 19 684
Susan Halimeh Germany 17 938 2.5× 223 1.1× 137 0.8× 138 1.3× 92 1.0× 73 1.3k
Shelley E. Crary United States 14 275 0.7× 173 0.9× 61 0.3× 45 0.4× 262 3.0× 36 640
Nina Salooja United Kingdom 14 318 0.8× 66 0.3× 71 0.4× 66 0.6× 88 1.0× 28 868
Hazel Tinegate United Kingdom 12 365 1.0× 127 0.7× 57 0.3× 47 0.4× 100 1.1× 18 798
Barry Kevane Ireland 15 211 0.6× 37 0.2× 220 1.3× 138 1.3× 71 0.8× 56 614
Oluwatoyosi A. Onwuemene United States 10 169 0.4× 59 0.3× 69 0.4× 51 0.5× 130 1.5× 42 454
Maja Jørgensen Denmark 10 295 0.8× 47 0.2× 235 1.3× 112 1.0× 177 2.0× 17 617

Countries citing papers authored by Ming Y. Lim

Since Specialization
Citations

This map shows the geographic impact of Ming Y. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Y. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Y. Lim more than expected).

Fields of papers citing papers by Ming Y. Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Y. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Y. Lim. The network helps show where Ming Y. Lim may publish in the future.

Co-authorship network of co-authors of Ming Y. Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Y. Lim. A scholar is included among the top collaborators of Ming Y. Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Y. Lim. Ming Y. Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cuker, Adam, David García, Ming Y. Lim, et al.. (2025). Foundations of systems-based hematology: thematic analysis of expert interviews to guide curriculums and promote growth. Blood Advances. 10(6). 2038–2046.
2.
3.
4.
Singh, Rishabh, Caroline Cromwell, Manila Gaddh, et al.. (2024). Comparative Analysis of Perioperative Anticoagulation Management Guidelines across U.S. Institutions. Blood. 144(Supplement 1). 5014–5014.
5.
Lim, Ming Y., George M. Rodgers, D. Ware Branch, & Sara E. Simonsen. (2024). Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single‐institution cohort study. Haemophilia. 30(2). 470–477. 1 indexed citations
6.
Ragni, Margaret V., J. B. Callis, Jonathan P. Schwartz, et al.. (2023). Observational cohort study of long‐term outcomes of liver transplantation in haemophilia. Haemophilia. 30(1). 87–97. 1 indexed citations
7.
Luo, M., et al.. (2023). An Unusual Case of Hyperhemolysis Syndrome and Delayed Hemolytic Transfusion Reaction due to Anti-Jk(a) and Anti-P1 Antibodies. SHILAP Revista de lepidopterología. 2023. 1–5. 1 indexed citations
8.
McFarland, Mary, et al.. (2023). Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review. Research and Practice in Thrombosis and Haemostasis. 7(7). 102219–102219. 6 indexed citations
9.
Lim, Ming Y., et al.. (2021). 36‐year‐old male with X‐linked congenital sideroblastic anemia presenting as chronic microcytic anemia with iron overload. International Journal of Laboratory Hematology. 44(1). 69–71. 2 indexed citations
10.
Wang, Tzu‐Fei, Lisa Baumann Kreuziger, Avi Leader, et al.. (2021). Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. Journal of Thrombosis and Haemostasis. 19(8). 2068–2081. 25 indexed citations
11.
May, Jori E., Alisa S. Wolberg, & Ming Y. Lim. (2021). Disorders of Fibrinogen and Fibrinolysis. Hematology/Oncology Clinics of North America. 35(6). 1197–1217. 26 indexed citations
12.
Lee, Shaun Wen Huey, et al.. (2021). Budget Impact of Emicizumab for Routine Prophylaxis of Bleeding Episodes in Patients With Hemophilia A With Inhibitors. Value in Health Regional Issues. 28. 7–13. 2 indexed citations
13.
Lim, Ming Y., et al.. (2017). Initial and long term impact of a multi-disciplinary task force in the diagnosis and management of heparin-induced thrombocytopenia. Journal of Thrombosis and Thrombolysis. 45(1). 130–134. 11 indexed citations
14.
Lim, Ming Y., Brenda Nielsen, Kristy Lee, et al.. (2014). Rituximab as first‐line treatment for the management of adult patients with non‐severe hemophilia A and inhibitors. Journal of Thrombosis and Haemostasis. 12(6). 897–901. 5 indexed citations
15.
Jamieson, Katarzyna & Ming Y. Lim. (2014). Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients. Clinical Interventions in Aging. 9. 753–753. 8 indexed citations
16.
Shariff, Zalilah Mohd, et al.. (2013). Relationship between family meals away from home and nutritional status of adolescents.. PubMed. 19(1). 25–35. 7 indexed citations
17.
Lim, Ming Y. & Rajiv K. Pruthi. (2012). Outcomes of management of acute coronary syndrome in patients with congenital bleeding disorders: A single center experience and review of the literature. Thrombosis Research. 130(3). 316–322. 19 indexed citations
18.
Lim, Ming Y. & Rajiv K. Pruthi. (2011). Cardiovascular disease risk factors. Blood Coagulation & Fibrinolysis. 22(5). 402–406. 57 indexed citations
19.
Lim, Ming Y. & Eddie L. Greene. (2011). 65-Year-Old Woman With Shortness of Breath and Dark Urine. Mayo Clinic Proceedings. 86(9). 912–915. 1 indexed citations
20.
Lim, Ming Y. & Mona Moufahim. (2008). Transnational Education Marketing (TNE) between the U.K. and China: A Critical Discourse Analysis of Institutional Marketing Communications.. Figshare. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melvin R. Mac Gillavry Breakdown of academic impact, for papers by Janet Birchall Breakdown of academic impact, for papers by Terry Gernsheimer Breakdown of academic impact, for papers by Susan Halimeh Breakdown of academic impact, for papers by Shelley E. Crary Breakdown of academic impact, for papers by Nina Salooja Breakdown of academic impact, for papers by Hazel Tinegate Breakdown of academic impact, for papers by Barry Kevane Breakdown of academic impact, for papers by Oluwatoyosi A. Onwuemene Breakdown of academic impact, for papers by Maja Jørgensen
Rankless by CCL
2026